{"id":"https://openalex.org/W2560477339","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.1106","title":"Alterations in breast cancer resistance protein in human placentas exposed to chemotherapy.","display_name":"Alterations in breast cancer resistance protein in human placentas exposed to chemotherapy.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2560477339","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.1106","mag":"2560477339"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.1106","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.1106","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.1106","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046625480","display_name":"M. G. Holland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. G. Holland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A. McCampbell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. McCampbell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014713051","display_name":"Jennifer Keating Litton","orcid":"https://orcid.org/0000-0001-8390-4985","observed_orcids":["https://orcid.org/0000-0001-8390-4985"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. K. Litton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010686398","display_name":"Richard L. Theriault","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. L. Theriault","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064203781","display_name":"Mildred M Ramirez","orcid":"https://orcid.org/0000-0003-1032-1273","observed_orcids":["https://orcid.org/0000-0003-1032-1273"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. M. Ramirez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"1106","last_page":"1106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13279","display_name":"Safe Handling of Antineoplastic Drugs","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/3609","display_name":"Occupational Therapy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.9800000190734863},{"id":"https://openalex.org/keywords/placenta","display_name":"placenta","score":0.7289999723434448},{"id":"https://openalex.org/keywords/pregnancy-associated-breast-cancer","display_name":"pregnancy-associated breast cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8610000014305115},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/fac-regimen","display_name":"FAC regimen","score":0.7590000033378601},{"id":"https://openalex.org/keywords/placental-drug-transfer","display_name":"maternal-fetal drug transfer","score":0.7089999914169312},{"id":"https://openalex.org/keywords/chorionic-villi","display_name":"chorionic villi","score":0.800000011920929},{"id":"https://openalex.org/keywords/immunostaining","display_name":"immunostaining","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7839616537094116},{"id":"https://openalex.org/C512196","wikidata":"https://www.wikidata.org/wiki/Q4650095","display_name":"Abcg2","level":5,"score":0.595916748046875},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5869913101196289},{"id":"https://openalex.org/C36201501","wikidata":"https://www.wikidata.org/wiki/Q17907816","display_name":"Multidrug resistance-associated protein 2","level":5,"score":0.5528042316436768},{"id":"https://openalex.org/C2776953305","wikidata":"https://www.wikidata.org/wiki/Q1212935","display_name":"Placenta","level":4,"score":0.5036820769309998},{"id":"https://openalex.org/C4224716","wikidata":"https://www.wikidata.org/wiki/Q10859258","display_name":"Immunostaining","level":3,"score":0.4966943860054016},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4916835427284241},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4901491105556488},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46524178981781006},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.45584315061569214},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4311872124671936},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41051024198532104},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.4059925675392151},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3666234016418457},{"id":"https://openalex.org/C172680121","wikidata":"https://www.wikidata.org/wiki/Q26513","display_name":"Fetus","level":3,"score":0.21370789408683777},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.14790382981300354},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13781708478927612},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.1158551573753357},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.1106","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.1106","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.1106","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1965127293","https://openalex.org/W7135564384","https://openalex.org/W2165599641","https://openalex.org/W2011530842","https://openalex.org/W2737319724","https://openalex.org/W2045841512","https://openalex.org/W2204482215","https://openalex.org/W2144157364","https://openalex.org/W2161658343","https://openalex.org/W1978953108"],"abstract_inverted_index":{"1106":[0],"Background:":[1],"In":[2],"women":[3,86,303],"with":[4,87,224,304],"pregnancy":[5,269],"associated":[6],"breast":[7],"cancer":[8,30],"(PABC),":[9],"fetal":[10],"exposure":[11,65],"to":[12,24,66,122,156,168,206,271,289],"chemotherapy":[13,57,67,233,287],"during":[14,268],"the":[15,38,47,59,75,113,123,137,157,232,290],"second":[16],"/":[17],"third":[18],"trimester":[19],"has":[20,50],"not":[21,237],"been":[22,51],"linked":[23],"considerable":[25],"neonatal":[26],"adverse":[27],"outcome.":[28],"Breast":[29],"resistance":[31],"protein":[32],"(BCRP)":[33],"is":[34],"a":[35,71,106,150,238],"member":[36],"of":[37,56,74,250,266,286],"ATP-binding":[39],"cassette":[40],"(ABCG2)":[41],"efflux":[42],"transporter":[43],"family":[44],"localized":[45],"in":[46,53,130,163,241,279,301],"placenta.":[48,60],"BCRP":[49,124,274,280],"implicated":[52],"preventing":[54],"passage":[55],"across":[58],"Our":[61],"study":[62],"examines":[63],"if":[64],"regimens":[68],"including":[69],"adriamycin,":[70],"known":[72],"substrate":[73],"transporter,":[76],"changes":[77],"placental":[78,273],"immunostaining":[79],"for":[80,100,185,195,213,283],"BCRP.":[81],"Methods:":[82],"13":[83],"placentas":[84],"from":[85],"(PABC)":[88],"who":[89],"received":[90],"5-fluorouracil,":[91],"adriamycin":[92],"and":[93,147,189,253],"cyclophosphamide":[94],"(FAC),":[95],"were":[96,103,145,161,166],"collected.":[97],"Controls":[98],"matched":[99],"gestational":[101],"age":[102],"identified":[104],"at":[105],"1:1":[107],"ratio.":[108],"Immunohistochemistry":[109],"was":[110,128,172,183,198,218,236],"performed":[111,173],"using":[112,136,149],"BXP-21":[114],"monoclonal":[115],"antibody":[116],"(Santa":[117],"Cruz":[118],"Biotechnology,":[119],"Inc)":[120],"specific":[121],"protein.":[125],"Staining":[126],"intensity":[127],"quantified":[129],"10":[131],"chorionic":[132],"villi":[133],"per":[134],"slide":[135],"Image":[138],"Pro":[139],"(Version":[140],"7.0)":[141],"software.":[142],"All":[143],"measurements":[144],"standardized":[146],"taken":[148],"grey":[151],"value":[152],"scale":[153],"(gvs)":[154],"according":[155],"software":[158,176],"specifications.":[159],"Samples":[160],"run":[162],"triplicate.":[164],"Investigators":[165],"blinded":[167],"case/control":[169],"status.":[170],"Analysis":[171],"(STATA":[174],"statistical":[175],"package,":[177],"version":[178],"10.0).":[179],"Kruskal-Wallis":[180,215],"rank":[181,216],"test":[182,217],"utilized":[184],"comparison":[186],"between":[187,243],"case":[188,196],"control":[190],"groups.":[191],"Results:":[192],"Median":[193],"density":[194,242],"samples":[197],"107.13":[199],"(IQR":[200,208],"101.1":[201],"\u2013":[202,210],"118.7)":[203],"gvs":[204,212],"compared":[205],"78.97":[207],"77.09":[209],"87.9)":[211],"controls.":[214,230],"significant":[219,239],"(":[220],"p":[221,261],"=":[222,259,262],"0.0001),":[223],"cases":[225,245],"scoring":[226],"significantly":[227],"higher":[228],"than":[229],"Within":[231],"group,":[234],"there":[235],"difference":[240],"those":[244,254],"receiving":[246,255],"\u2264":[247],"4":[248],"cycles":[249,257],"FAC":[251,267],"(n=7)":[252],"\u22655":[256],"(n":[258],"6),":[260],"0.78.":[263],"Conclusions:":[264],"Administration":[265],"appears":[270],"increase":[272,278],"immunostaining.":[275],"The":[276],"observed":[277],"may":[281],"account":[282],"diminished":[284],"transfer":[285],"agents":[288],"fetus,":[291],"therefore":[292],"limiting":[293],"exposure.":[294],"This":[295],"novel":[296],"finding":[297],"could":[298],"have":[299],"implications":[300],"treating":[302],"PABC.":[305]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-12-16T00:00:00"}